Viral Infections : HERPES ZOSTER (SHINGLES) Flashcards
HERPES ZOSTER (SHINGLES) Clinical Feature prodrome, area
unilateral dermatomal eruption occurring 3-5 d after pain and paresthesia of that dermatome
•typically involves a single
dermatome; lesions rarely cross the midline
HERPES ZOSTER (SHINGLES) lesion
vesicles, bullae, and pustules on an erythematous, edematous base
lesions may become eroded/ulcerated and last days to weeks
HERPES ZOSTER (SHINGLES) pain
pain can be pre-herpetic, synchronous with rash, or post-herpetic
HERPES ZOSTER (SHINGLES) consecuences
severe post-herpetic neuralgia often occurs in elderly
HERPES ZOSTER (SHINGLES) Hutchinson’s sign
shingles on the tip of the nose signifies ocular involvement.
shingles in this area involves the nasociliary branch of the ophthalmic branch of the trigeminal
nerve (V1)
HERPES ZOSTER (SHINGLES) distribution:
thoracic (50%), trigeminal (10-20%), cervical (10-20%); disseminated in HIV
HERPES ZOSTER (SHINGLES) Etiology
caused by reactivation of VZV
HERPES ZOSTER (SHINGLES) risk factors
immunosuppression, old age, occasionally associated with hematologic malignancy
HERPES ZOSTER (SHINGLES) Investigations
none required, but can do Tzanck test, direct fluorescence antibody test, or viral culture to rule out HSV
HERPES ZOSTER (SHINGLES) Prevention
routine vaccination in 50+ yr old with Shingrix® (recombinant zoster vaccine) preferred to in 60+ yr old
with Zostavax® (live zoster vaccine
HERPES ZOSTER (SHINGLES) Management topical
compress with normal saline, Burow’s or betadine solution
HERPES ZOSTER (SHINGLES) Management oral antivirals:
famciclovir, valacyclovir, or acyclovir for 7 d; must initiate within 72 h to be of benefitt
HERPES ZOSTER (SHINGLES) Management analgesia:
NSAIDs, acetaminophen for mild-moderate pain; opioids if severe
HERPES ZOSTER (SHINGLES) Management post-herpetic neuralgia
TCAs, anticonvulsants (gabapentin, pregabalin)